Genomic Health Inc (GHDX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GHDX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Genomic Health Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2019)
(Jun 30 2019) (Mar 31 2019) (Dec 31 2018) (Sep 30 2018)
Assets
Cash & cash equivalent71.96
Marketable Securities, Current SH203.47
Cash & Short-term Investments274.00
Accounts receivable55.88
Prepaid Expense And Other Assets Current13.73
Total Current Assets345.04
Equipment/Property/Plant Net46.49
Long-term investments0.00
Other Assets, Noncurrent68.88
Total Assets460.41
Liabilities
Accounts Payable, Current AC6.43
Accrued Liabilities, Current46.68
Other Liabilities, Current4.79
Taxes Payable0.00
Total Current Liabilities57.90
Total Long-term Debt0.00
Other liabilities, Noncurrent53.14
Total Liabilities111.04
Stockholders' Equity
Treasury Stock Common Value-
Common Stock Value0.00
Additional Paid In Capital Common Stock538.08
Retained Earnings / Accumulated Deficit-188.76
Other Equity0.04
Common Stockholder's Equity349.37
Total Stockholder's Equity349.37
Liabilities & Stockholder's Equity460.41
4 historic quarters locked

Sign in to unlock the full Genomic Health Inc balance sheet history.

About GHDX Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.